The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


Background: Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF.Methods: A cross-sectional study was performed, from 2009 to 2011, at University of Campinas - UNICAMP. We analyzed 180 patients for the most frequent mutations in the CFTR gene, presence of the ACE gene D/I polymorphism and clinical characteristics of CF.Results: There was an association of the D/D genotype with early initiation of clinical manifestations (OR: 1.519, CI: 1.074 to 2.146), bacterium Burkholderia cepacia colonization (OR: 3.309, CI: 1.476 to 6.256) and Bhalla score (BS) (p = 0.015). The association was observed in subgroups of patients which were defined by their CFTR mutation genotype (all patients; subgroup I: no mutation detected; subgroup II: one CFTR allele identified to mutation class I, II or III; subgroup III: both CFTR alleles identified to mutation class I, II and/or III).Conclusion: An association between the D allele in the ACE gene and the severity of CF was found in our study. © 2012 Marson et al.; licensee BioMed Central Ltd.




Marson, F. A. L., Bertuzzo, C. S., Hortencio, T. D. R., Ribeiro, J. D., Bonadia, L. C., & Ribeiro, A. F. (2012). The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis. BMC Pulmonary Medicine, 12.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free